Chief Scientific Officer
Sriram Iyer (“Sri”) is a physician‑scientist and an entrepreneur with a proven track record of translating ideas and patents to commercial products useful in clinical practice. Since founding Vascular Therapies, he has provided leadership and strategic input for all operational, product development and financing activities of the company.
An interventional cardiologist and vascular medicine specialist with more than 25 years of experience in coronary, peripheral vascular and carotid interventions, he served as the Associate Chairman of the Department of Cardiology and the Director of Peripheral Vascular and Carotid Interventions at Lenox Hill Hospital in New York City. Sri is recognized worldwide for his pioneering work and contributions to angioplasty and stenting for treatment of extra‑cranial carotid artery disease. A gifted teacher, he has mentored and trained several cardiologists, many of whom are now directors and department heads in hospitals in the US and abroad.
His experience as an investigator in several FDA regulated clinical trials has provided him a solid understanding of the rigor and the regulatory expectations surrounding product approval. Sri has published extensively and holds several patents including methods for treating failure of hemodialysis vascular accesses and vascular grafts. He is a Fellow of the American College of Cardiology (FACC), a Fellow of the Society for Cardiac Angiography and Interventions (FSCAI) and received his M.B; B.S.; M.D. (General Medicine) and D.M. (Cardiology) degrees from the University of Bombay, India.